Soft Tissue Sarcoma
📧 Sign up to get email alerts when something new happens for Soft Tissue Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: GRID Therapy for Extremity Soft Tissue Sarcoma [NA]
Clinical trial update on GRID therapy for extremity soft tissue sarcoma. The trial is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-10Clinical Trial Update: Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas
Clinical trial update for a study on financial toxicity in patients with resected soft tissue and bone sarcomas; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: A Multicenter, Single-arm, Prospective Phase II Clinical Study of Epalrotokewali Combined With Eribulin, Anlotinib, and Radiotherapy for the Treatment of Patients With Advanced Soft Tissue Sarcoma. [Phase 2]
Phase II multicenter, single-arm trial evaluating Epalrotokewali combined with eribulin, anlotinib, and radiotherapy for advanced soft tissu…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology [Phase 4]
Phase 4 clinical trial comparing low molecular weight heparin versus aspirin for venous thromboembolism prophylaxis in orthopedic oncology, …
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial is evaluating infusion of NY-ESO-1–specific TCR-engineered lymphocytes in patients with NY-ESO-1-expressing…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas [Phase 3]
Phase 3 trial evaluating intensified peri-operative chemotherapy in high-risk CINSARC patients with resectable non-metastatic soft-tissue sa…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma [EARLY_Phase 1]
An early-phase Phase 1 clinical trial evaluating immunotherapy in combination with radiotherapy for metastatic soft tissue sarcoma. The stud…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Clinical Trial to Treat Stage IV Cancer Patients [Phase 1]
Moonshot Antibodies announced a Phase 1 trial enrolling patients with Stage IV soft tissue sarcoma.
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Digital Art Therapy for Young Cancer Survivors [NA]
This document reports on a clinical trial studying digital art therapy for young cancer survivors, which is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Efficacy of Pre-operative Prehabilitation in Patients With Limb Sarcoma [Phase 2]
This is a Phase 2 clinical trial evaluating pre-operative prehabilitation in patients with limb soft tissue sarcoma and is currently recruit…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: The Value of a Risk Prediction Tool (PERSARC) for Effective Treatment Decisions of Soft-tissue Sarcomas Patients [NA]
A clinical trial update notes an active-not-recruiting study evaluating PERSARC, a risk-prediction tool, to guide treatment decisions in sof…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: A Prospective, Single-arm, Multicenter Exploratory Clinical Study of Anlotinib Combined With Bempegaldesleukin and Conventional Chemoradiotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Soft Tissue Sarcoma. [Phase 2]
A Phase 2 exploratory, single-arm multicenter trial evaluating anlotinib plus bempegaldesleukin with standard chemoradiotherapy for unresect…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors. [NA]
This clinical trial update describes a post-treatment program to identify and manage complications related to oncology or hematology treatme…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors [EARLY_Phase 1]
Phase 0 multicenter study evaluating pharmacodynamic effects of intratumoral microdosing with PBA-0111 in solid tumors; the trial is current…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Development of Innovative Preclinical Ex Vivo Models for the Study of Sarcomas and Metastases From Solid Tumors
The study aims to develop innovative preclinical ex vivo models to study sarcomas and metastases from solid tumors and is currently recruiti…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Study Comparing Negative Pressure Dressing vs Conventional in Patients With Resected STS After Radiotherapy [NA]
A clinical trial is evaluating negative pressure dressing compared with conventional dressings for patients with resected soft tissue sarcom…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILE
Describes a descriptive cohort of French patients treated with carbon ion therapy for various cancers, reported outside a PHRC-ETOILE progra…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: Study Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma [Phase 1]
Phase 1 study evaluating MEDI5752 in combination with stereotactic radiotherapy for metastatic soft tissue sarcoma; the trial is currently a…
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
This clinical trial update describes a Memorial Sloan Kettering Cancer Center study investigating novel biochemical and molecular determinan…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers [NA]
A multi-cancer prospective study evaluating double-positive circulating cells (CD45+ tumor marker) in several types of metastatic cancers; r…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3) [Phase 3]
Phase 3 clinical trial investigating intratumoral INT230-6 versus US standard of care in adults with soft tissue sarcoma; the study is curre…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma [Phase 2]
A Phase 2 trial evaluating MASCT-I in combination with doxorubicin and ifosfamide as first-line therapy for advanced soft tissue sarcoma is …
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration [Phase 2]
A Phase 2 clinical trial evaluating abemaciclib for bone and soft tissue sarcomas with CDK pathway alterations is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: A Trial of Cadonilimab With Adriamycin in Patients With Advanced Soft Tissue Sarcoma [Phase 2]
This clinical trial update describes a Phase 2 study evaluating Cadonilimab in combination with Adriamycin (doxorubicin) in patients with ad…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Pazopanib With or Without Pembrolizumab for Metastatic Soft Tissue Sarcoma [Phase 2]
A Phase 2 clinical trial is evaluating pazopanib with or without pembrolizumab for metastatic soft tissue sarcoma. The study is currently re…